Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
about
Proteomics Research in SchizophreniaNeuroproteomics in neurotraumaProteomic analysis of mitochondria reveals a metabolic switch from fatty acid oxidation to glycolysis in the failing heart.Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.The impact of blood contamination on the proteome of cerebrospinal fluid.Stem cell proteomes: a profile of human mesenchymal stem cells derived from umbilical cord blood.Proteome analysis of chick embryonic cerebrospinal fluid.Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation.Analysis of chicken serum proteome and differential protein expression during development in single-comb White Leghorn hens.Proteomic analysis of the mouse brain following protein enrichment by preparative electrophoresis.Proteomics in clinical trials and practice: present uses and future promise.An integrated map of the murine hippocampal proteome based upon five mouse strains.Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration.Biomarker discovery in psychiatric disorders.Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression.Age-associated changes in synaptic lipid raft proteins revealed by two-dimensional fluorescence difference gel electrophoresis.Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis.Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.Schizophrenia proteomics: biomarkers on the path to laboratory medicine?Differences in serum protein 2D gel electrophoresis patterns of Przewalski's (Mongolian wild horse) and thoroughbred horses.Application of proteomics technologies in the investigation of the brain.Toxicoproteomics: proteomics applied to toxicology and pathology.Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairmentDissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers.Translational research in central nervous system drug discovery.Proteomics-driven progress in neurodegeneration research.Genetics, transcriptomics, and proteomics of Alzheimer's diseaseProteomic research in psychiatry.Proteomic studies on the development of the central nervous system and beyond.Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?Systems biology, bioinformatics, and biomarkers in neuropsychiatry.Blood biomarker discovery in drug-free schizophrenia: the contributionof proteomics and multiplex immunoassays.Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.Study of rat hypothalamic proteome by HPLC/ESI ion trap and HPLC/ESI-Q-TOF MS.Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders.Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain.Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots.Characterization of mature rat oligodendrocytes: a proteomic approach.
P2860
Q26766821-1417DFBD-834D-405B-9A6B-894A3B991D45Q28299064-56490D74-40B0-4EC3-A4B5-84372133099BQ30915732-9A5AF14B-2C8E-4565-B943-13216A92D09BQ31052140-D976ECF8-63A0-4FA4-9688-EF39C0D5AC1BQ31143697-21884C5B-F7FF-4658-8398-9284255084FCQ33217620-FF10F1D3-246B-4E5F-9B5F-B1DE578F2167Q33227168-28ECD80D-4724-478C-8016-D3F7EDD9CAA4Q33230150-B3FFD81B-772D-424A-B399-827710F5665BQ33233800-C7785C87-F29D-4C2A-BCDE-49ADBD7AE0D8Q33235542-9CF3FB4B-84CF-466D-8435-B39CE44093EDQ33245305-CB578C1D-322C-4556-89B9-D941E6CD6C75Q33248674-763F163B-EDA5-4B58-8788-A6DE665EEABBQ33294428-CE7D9EA5-0781-4EDC-B241-F9674C701892Q33338835-3800092C-11CE-4104-86CD-B5B2B266E81BQ33371612-6C57FD88-BF19-4924-A22E-7736E516EF1EQ33402521-51832973-C403-4D84-982E-B6C5AE00FBB6Q33998390-88CBF453-F6A9-4AD8-A602-0901356CABA1Q34888915-778DC61E-D4A2-490B-8D8C-5990069825CEQ34928687-19E4D24A-10CA-4932-B456-A0EF80952040Q34973585-F4E0D739-BE5B-4625-BA0E-732F57019CA4Q35532618-75BAC23F-137B-4BB5-AD40-802ACA03C10CQ35767749-F68A120C-48C8-43C1-BC69-DC05CDE6C83EQ35973576-12497680-7D9D-416F-A317-89E2FCBAE9C8Q36121837-C614E47F-761B-4DDC-B5F6-99CD312C9B00Q36168593-4CB76A57-1DF0-4012-8848-A89C762F61DAQ36401418-36F987C0-8A22-41E0-8B66-E74650D19346Q36429201-B639147A-BDBF-4519-B2E3-7A5CD5403AB6Q36466472-2A2571DF-54CD-4DC3-A2B8-1544FFA2FB22Q37689362-66B9C8E4-8691-4FCA-A3F4-17DA81D21F69Q37767612-6292C392-F874-4FFD-9D96-A7C8D37A09CBQ37968946-80278D8E-6732-4B83-B3DD-17F4D2A8F422Q38069972-C09D2037-9B7D-445A-808E-F857A787C13FQ38807041-91A342E2-A70C-4520-8A2B-D06604408240Q38809444-2331CE2A-467E-4AA3-96F6-050F758975FAQ38844925-CB7C3D56-B456-402D-BCE9-6A61D3B85F34Q44140058-098F2DE5-C734-4E38-B2EE-D12A5D7EF544Q46599874-63F0039E-C5D4-4D19-926A-77ECAC0F203AQ47213104-D02B3A34-B5E7-4986-9FE8-75D34A8A1A5BQ47241901-2DC3B682-CDE3-44E1-A054-4D61BB6BD281Q48198699-57C3E684-3C0F-4A20-BA6B-983831B3074B
P2860
Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
@ast
Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
@en
type
label
Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
@ast
Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
@en
prefLabel
Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
@ast
Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
@en
P2093
P2860
P921
P1433
P1476
Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
@en
P2093
Fountoulakis M
Lindpaintner K
P2860
P2888
P356
10.1007/S00726-003-0356-6
P577
2003-07-01T00:00:00Z